BPC-157: Complete Research Guide 2026

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). It is derived from a naturally occurring protein found in human gastric juice.

First isolated and characterised in the early 1990s, BPC-157 has since become one of the most extensively studied peptides in the research community, with over 100 published studies documenting its biological effects across multiple organ systems.

BPC-157's mechanism of action involves multiple biological pathways:

Growth Factor Modulation: BPC-157 has been shown to upregulate growth factors including VEGF (Vascular Endothelial Growth Factor), EGF (Epidermal Growth Factor), and FGF (Fibroblast Growth Factor), all critical for tissue repair.

Nitric Oxide System: The peptide interacts with the NO system, promoting vasodilation and improved blood flow to damaged tissues.

FAK-Paxillin Pathway: Research demonstrates BPC-157 activates the FAK-paxillin signalling pathway, which is essential for cell migration and wound healing.

Anti-inflammatory Action: BPC-157 modulates inflammatory cytokines, reducing excessive inflammation while supporting the body's natural healing cascade.

Dopaminergic System: Studies show BPC-157 interacts with the dopaminergic system, with implications for neuroprotection and gut-brain axis research.

Gastrointestinal Healing: BPC-157 was originally studied for its protective effects on the GI tract. Research has demonstrated positive outcomes in models of inflammatory bowel disease, gastric ulcers, and intestinal damage.

Musculoskeletal Repair: Extensive studies show BPC-157 accelerates healing of tendons, ligaments, muscles, and bones in animal models. Its effect on tendon-to-bone healing has been particularly notable.

Neuroprotection: Research indicates BPC-157 may protect against neurotoxic damage and support peripheral nerve regeneration. Studies have shown positive effects in models of traumatic brain injury and spinal cord damage.

Cardiovascular Effects: BPC-157 has demonstrated cardioprotective properties in research, including protection against arrhythmias and vascular damage.

Wound Healing: Topical and systemic administration of BPC-157 has been shown to accelerate wound closure and improve healing quality in animal studies.

- Molecular Formula: C₆₂H₉₈N₁₆O₂₂ - Molecular Weight: 1,419.53 g/mol - Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val - Classification: Pentadecapeptide (15 amino acids) - Stability: Stable in gastric juice (unique among peptides) - Half-life: Estimated 4-6 hours

BPC-157's remarkable stability in acidic conditions is unique among peptides and is part of what makes it suitable for various administration routes.

Tendon Healing (Staresinic et al., 2003): Demonstrated accelerated Achilles tendon healing in animal models, with BPC-157 groups showing significantly improved biomechanical properties.

Gut Protection (Sikiric et al., 1999): Landmark study showing BPC-157's protective effects against NSAID-induced gastrointestinal damage, establishing its cytoprotective properties.

Muscle Healing (Pevec et al., 2010): Showed BPC-157 accelerated healing of crush-injured muscle, improving both functional recovery and histological outcomes.

Neuroprotection (Sikiric et al., 2014): Comprehensive review of BPC-157's neuroprotective effects across multiple models of brain and nerve damage.

Peptides Pharma delivers BPC-157 in a lyophilized vial engineered for consistent, research-grade administration:

- Dosage: 10 mg per vial - Volume: 3 mL - Purity: >99% (HPLC verified) - Dosing Period: 30 days - Sterilisation: 0.22μm filtration + gamma ray - Storage: 2-8°C refrigerated - Shelf Life: 24 months - Manufacturing: GMP-certified facility (Switzerland)

Each vial contains lyophilized peptide and ready to use — no reconstitution required.